Clinical Trials Browser

INDUSTRY × Solid Tumors × Erlotinib Hydrochloride × Clear all

NCT01009073 2017-11-20

A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00754104 2011-01-19

Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Solid Tumors